Cost-effectiveness of serological tests for human visceral leishmaniasis in the Brazilian scenario.

ABSTRACT: Human visceral leishmaniasis (VL) is a severe and potentially fatal parasitic disease if not correctly diagnosed and treated. Brazil is one of the three countries most endemic for VL and, like most countries affected by this disease, has a large budget constraint for the incorporation of new health technologies. Although different diagnostic tests for VL are currently available in the country, economic studies evaluating diagnostic kits are scarce. The objective of this study was to conduct a cost-effectiveness analysis of the nine available diagnostic tests for human VL in HIV-infected and uninfected patients in Brazil. The perspective of analysis was the Brazilian public health system, and the outcome of interest was "cases diagnosed correctly". The costs of the tests were estimated usin

SUBMITTER: Freire ML 

PROVIDER: S-EPMC7544087 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature